Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: A case-control study in a Chinese population

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 297-305

  Wang, Haijian ^a,b   Hao, Bingtao ^c   Chen, Xiaoping ^c   Zhao, Naiqing ^a   Cheng, Gang ^a   Jiang, Yan ^a   Liu, Yang ^a   Lin, Chengzhao ^a   Tan, Wen ^d   Lu, Daru ^b   Wei, Qingyi ^e   Jin, Li ^b   Lin, Dongxin ^d   He, Fuchu ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d CANCER HOSPITAL   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ADRB2; Genetic susceptibility; Haplotype; Lung adenocarcinoma; NNK; SNP

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER PATIENT; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENETIC RISK; HAPLOTYPE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; POPULATION RISK; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS; SMOKING;

ANIMALIA; NICOTIANA TABACUM;

EID: 33746268313     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.018     Document Type: Article

References (35)

1. Minna J.D., Roth J.A., and Gazdar A.F. Focus on lung cancer. Cancer Cell 1 (2002) 49-52
2. Shields P.G. Molecular epidemiology of smoking and lung cancer. Oncogene 21 (2002) 6870-6876
3. Schuller H.M., Witschi H.P., Nylen E., Joshi P.A., Correa E., and Becker K.L. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res. 50 (1990) 1960-1965
4. Wynder E.L., and Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res. 54 (1994) 5284-5295
5. Su T., Bao Z., Zhang Q.Y., Smith T.J., Hong J.Y., and Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 60 (2000) 5074-5079
6. Zhang X., Su T., Zhang Q.Y., Gu J., Caggana M., Li H., et al. Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J. Pharmacol. Exp. Ther. 302 (2002) 416-423
7. Wang H., Tan W., Hao B., Miao X., Zhou G., He F., et al. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 63 (2003) 8057-8061
8. Schuller H.M., Tithof P.K., Williams M., and Plummer III H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 59 (1999) 4510-4515
9. Schuller H.M. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat. Rev. Cancer 2 (2002) 455-463
10. Leineweber K., and Brodde O.E. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci. 74 (2004) 2803-2814
11. Israel E., Chinchilli V.M., Ford J.G., Boushey H.A., Chemiack R., Craig T.J., et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 (2004) 1505-1512
12. Drysdale C.M., McGraw D.W., Stack C.B., Stephens J.C., Judson R.S., Nandabalan K., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA 97 (2000) 10483-10488
13. Boffetta P., Ye W., Boman G., and Nyren O. Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur. Respir. J. 19 (2002) 127-133
14. Park P.G., Merryman J., Orloff M., and Schuller H.M. Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Res. 55 (1995) 3504-3508
15. Wang H., Hao B., Zhou K., Chen X., Wu S., Zhou G., et al. Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association studies. Ann. Hum. Genet. 68 (2004) 563-573
16. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
17. Ding K., Zhou K., He F., and Shen Y. LDA-a java-based linkage disequilibrium analyzer. Bioinformatics 19 (2003) 2147-2148
18. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59 (1995) 97-105
19. Wallenstein S., Hodge S.E., and Weston A. Logistic regression model for analyzing extended haplotype data. Genet. Epidemiol. 15 (1998) 173-181
20. Schaid D.J., and Jacobsen S.J. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am. J. Epidemiol. 149 (1999) 706-711
21. Radzikowska E., Roszkowski K., and Glaz P. Lung cancer in patients under 50 years old. Lung Cancer 33 (2001) 203-211
22. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17 (2001) 502-510
23. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33 (2003) 177-182
24. Harris R.E., Schuller H.M., Bell J.L., Lu P.Y., and Alshafie G.A. Association of nonsteroidal anti-inflammatory drugs (NSAIDs) and anti-hypertensive medications (AHMs) with lung cancer among smokers and in a hamster model of NNK-induced lung cancer. Proc. Am. Assoc. Cancer Res. 42 (2001) 1424
25. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 967-986
26. Salanti G., Amountza G., Ntzani E.E., and Ioannidis J.P. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur. J. Hum. Genet. 13 (2005) 840-848
27. Chu J.Y., Huang W., Kuang S.Q., Wang J.M., Xu J.J., Chu Z.T., et al. Genetic relationship of populations in China. Proc. Natl Acad. Sci. USA 95 (1998) 11763-11768
28. Green S.A., Turki J., Innis M., and Liggett S.B. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33 (1994) 9414-9419
29. Contopoulos-Ioannidis D.G., Manoli E.N., and Ioannidis J.P. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J. Allergy Clin. Immunol. 115 (2005) 963-972
30. Rioux N., and Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 19 (1998) 1393-1400
31. Rioux N., and Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res. 58 (1998) 5354-5360
32. Drazen J.M., Yandava C.N., Dube L., Szczerback N., Hippensteel R., Pillari A., et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat. Genet. 22 (1999) 168-170
33. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat. Genet. 29 (2001) 306-309
34. Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G., and Ioannidis J.P. Establishment of genetic associations for complex diseases is independent of early study findings. Eur. J. Hum. Genet. 12 (2004) 762-769
35. Easterbrook P.J., Berlin J.A., Gopalan R., and Matthews D.R. Publication bias in clinical research. Lancet 337 (1991) 867-872